Six readers
| reader | found | score |
|---|---|---|
| genetics Open Targets | no genetic evidence; overall 0.11 from other evidence | 0.00 |
| cell type Human Protein Atlas | group enriched outside the brain (t-cells) | 0.10 |
| chemistry Open Targets | compounds already reach it: amg-811, fontolizumab, emapalumab | 0.90 |
| trials ClinicalTrials.gov | 6 Parkinson's trials, 2 stopped | 0.73 |
| literature PubMed | 14 Parkinson's papers of 3,365 | 0.64 |
| pathways Reactome | 7 pathways; mostly immune signalling | 0.90 |
No case: the score is under the bar. Receipt 2423
Sealed predictions
- IFNG in dopamine neurons, braakn/a → n/areceipt 2429
Swarm cases
receipt 2429: IFNG in dopamine neurons, braak
- cell type
- IFNG is not measured in dopamine neurons; looking elsewhere.
- cell type
- no other cell group does better.
- axis
- no measure beats "tracks Braak Lewy-body stage" for IFNG in dopamine neurons.
case closed: nothing better to follow up.
Receipts
loading the receipts